[Table_PicQuote] 聚焦战略主业夯实壁垒，稳定币相关领域 抢先布局 [Table_Balance] 股票研究 /[Table_Date] 2025.06.13 2025-06-19 本报告导读： 公司坚持聚焦核心业务和战略客户，信贷和信用卡业务在银行 IT 领域持续领跑，同 时 AI+国际化构筑增长双引擎，在稳定币领域亦有抢先布局。 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 1,936 | 1,766 | 2,038 | 2,386 | 2,830 | | (+/-)% | -2.0% | -8.8% | 15.4% | 17.1% | 18.6% | | 净利润（归母） | 117 | 78 | 93 | 122 | 163 | | (+/-)% | 91.9% | -33.6% | 19.8% | 31.8% | 33.0% | | 每股净收益（元） | 0.25 | 0.17 | 0.20 ...

[Table_Title] 研究报告 Research Report 19 Jun 2025 美国航空航天与国防 US Aerospace and National Defense 超越表象：发掘以色列冲突中的结构性价值 Beyond the Headlines: Uncovering Structural Value in the A&D Supply Chain 杨斌 Bin Yang bin.yang@htisec.com [Table_yemei1] 热点速评 Flash Analysis [(Table_summary] Please see APPENDIX 1 for English summary) 核心观点： 结构性投资机遇存在于这些订单的连锁反应之中：从实战消耗驱动的、确定性极高的弹药补库需求，到生产瓶颈 所凸显的上游供应商价值，再到被市场忽视的、代表未来战争形态的直接商业采购（DCS）。具体而言，短期最确 定的需求是价值超 10 亿美元的拦截弹补库；而 JDAM 等弹药长达 1-2 年的交付瓶颈，则为关键上游企业创造了超 越主承包商的投资弹性。最后，DCS 渠道的动向揭示了一条与传统国防 ...

[Table_Title] 研究报告 Research Report 18 Jun 2025 VISA VISA (V US) 稳定币冲击 VISA，影响几何？ The Stablecoins Challenge to VISA 寇媛媛 Yuanyuan Kou 陈芳园 Ashley Chen yy.kou@htisec.com ashley.fy.chen@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) 近日 VISA 股价出现显著波动，我们认为市场担忧大型零售平台发行稳定币可能影响支付生态，对 VISA 等传统支付 网络构成潜在冲击，是此次股价下行的主要诱因。自 6 月 13 日《华尔街日报》发布《Walmart 和 Amazon 正在探 索发行自己的稳定币》以来，市场对大型零售平台可能重构支付生态的担忧迅速升温，支付类股票集体承压。其 中，行业龙头 VISA 和 Mastercard 分别下跌 5.4%和 4.6%。投资者担心，若平台型稳定币 ...

Investment Rating - The report rates the pharmaceutical industry as "Outperform" [1][2] - The sub-industries of pharmaceutical manufacturing and pharmaceutical services are also rated as "Outperform" [2] Core Insights - Continuous recommendation of innovative drugs and devices, with a positive outlook on companies such as Jiangsu Heng Rui Medicine, Hansoh Pharmaceutical, Sichuan Kelun Pharmaceutical, Huadong Medicine, 3SBio, CSPC Pharmaceutical Group, and Changchun High-tech Industry [4][23] - The report emphasizes that centralized procurement optimization is expected to benefit innovative drugs and devices, as highlighted in a State Council meeting on June 13, 2025 [24] - The A-Shares pharmaceutical sector outperformed the market in the second week of June 2025, with a 1.4% increase compared to a 0.2% decrease in the Shanghai Composite Index [6][25] - The Hong Kong and U.S. pharmaceutical sectors also outperformed the market during the same period, with significant gains in the Hang Seng Healthcare and Biological Technology indices [20][26] Summary by Sections Continuous Recommendation of Innovative Drugs and Devices - The report maintains a positive outlook on innovative drugs, highlighting the potential for value re-evaluation in companies like Heng Rui Medicine, Hansoh Pharmaceutical, and others [4][5] - Biopharma/Biotech companies such as Kelun Biotech, Innovent Biologics, and BeiGene are also recommended for their growth potential [4][5] Performance of A-Shares Pharmaceutical Sector - In the second week of June 2025, the A-Shares pharmaceutical sector rose by 1.4%, ranking 4th among Shenwan primary industries [6][25] - Notable individual stock performances included Tibet Aim Pharm. Inc. (+38.5%) and Beijing Science Sun Pharmaceutical (+36.4%) [25][14] Performance of Hong Kong and U.S. Pharmaceutical Sectors - The Hang Seng Healthcare index increased by 8.8%, and the Biological Technology index rose by 10.5% during the same period [20][26] - In the U.S., the S&P 500 Healthcare Select Sector rose by 1.2%, with top gainers including Regeneron (+7%) and Eli Lilly (+6%) [20][26]

Investment Rating - The report assigns an "Outperform" rating to ADNOC Distribution, indicating an expected relative return exceeding 10% over the next 12-18 months [19]. Core Insights - ADNOC Distribution is recognized for its differentiated retail model, focusing on shareholder cash returns and strategic expansion in customer base and property management [2][3]. - The company is expanding its non-fuel retail business, which contributes nearly 10% of total retail revenue but has the highest profit margins, maintaining a gross margin of over 50% [4]. - The company aims to increase its electric vehicle (EV) charging points significantly, targeting a 10-15 times increase by FY28 compared to FY23 [4]. - Expansion into Saudi Arabia and Egypt is seen as crucial for mid-term growth, leveraging a light-asset model to increase station numbers in these markets [4]. Company Overview - ADNOC Distribution operates primarily in the UAE, with a presence in Saudi Arabia and Egypt, and is 77% owned by the ADNOC Group [3]. - As of the end of FY24, the company operates 896 fuel stations, with a goal of reaching 1,000 by FY28 [3]. - The company also manages 373 ADNOC Oasis convenience stores and provides various services including car inspections and EV charging [3]. Financial Performance - The company's dividend policy is attractive, with plans to distribute $700 million or at least 75% of net profits as dividends from FY24 to FY28, translating to an approximate 6.0% dividend yield [5].

25 年一季度业绩亮眼，全面拥抱 AI 涂鸦智能(TUYA.N) 2025 年一季报点评 股票研究 /[Table_Date] 2025.6.17 [Table_Industry] 计算机 [Table_Invest] [Table_CurPrice] 当前价格(美元)： 2.42 本报告导读： 25 年一季度表现亮眼，公司的平台模式具有高粘性特征，关税因素带来的不确定性 增强。 股 投资要点： | 财务摘要（百万美元） | 2022A | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | --- | | 营业收入 | 208.17 | 229.99 | 298.62 | 324.93 | 361.06 | 409.64 | | (+/-)% | -31.1% | 10.5% | 29.8% | 8.8% | 11.1% | 13.5% | | 毛利润 | 89.42 | 106.66 | 141.43 | 151.30 | 169.25 | 193.11 | | 归母净利润 | -146.18 | -6 ...

现金造血能力快速恢复，鸿蒙操作系统利好终端安全业务 亚信安全(688225) 公司跟踪点评 股票研究 /[Table_Date] 2025.06.17 2025-06-17 计算机 [Table_Industry] /信息科技 [Table_Invest] 评级： 增持 [Table_Target] 目标价格： 33.40 本报告导读： 数智业务并入大幅提升公司盈利能力；网络安全标准化产品扩张、人效提升和数智 业务等因素正快速恢复公司现金造血能力；鸿蒙操作系统利好终端安全业务。 投资要点： 网络安全业务线外部扩大标准化产品竞争优势，内部降本增效。 2024 年，公司标准化产品收入同比增长 7.4%，占网络安全业务营收 的比例提升至 47.3%；公司网络安全业务毛利率增长至 61.35%，提 升 13.53 个百分点。同时，公司销售费用、研发费用、管理费用三 项费用合计同比增长仅 2.1%，控费增效举措显著有效。我们认为， 公司的标准化产品外延扩张，内部人效提升，数智业务合并三大举 措正在实现现金造血的快速修复。 | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 202 ...

首次覆盖: AI 原生智能体和算力业务打开成长空间 中科金财(002657) ——中科金财首次覆盖 股票研究 /[Table_Date] 2025.06.17 2025-06-17 计算机 [Table_Industry] /信息科技 [Table_Invest] 首次覆盖 评级 增持 本报告导读： 公司是老牌金融科技和数据中心服务厂商，创新推出 AI-Native 技术架构，布局 AI 原生智能体，并探索拓展算力服务业务，有望乘 AI 东风实现加速成长。 投资要点： | [Table_Finance] 财务摘要（百万元） | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 1,002 | 1,167 | 1,684 | 2,319 | 2,861 | | (+/-)% | -18.7% | 16.5% | 44.3% | 37.7% | 23.4% | | 净利润（归母） | -108 | -55 | -14 | 23 | 46 | | (+/-)% | 35.7% | 48.8% ...

Investment Rating - The report maintains an "Outperform" rating for the company with a target price of RMB 38.97 [1][10]. Core Insights - The company is experiencing steady improvement in operational quality, with AI products and services achieving breakthrough growth, leading the intelligent transformation in the industrial software sector [1][10]. - The forecast for EPS is RMB 0.97 for 2025, RMB 1.26 for 2026, and RMB 1.65 for 2027, with a forward PE of 40x assigned for 2025 [10][11]. Financial Summary - Revenue is projected to grow from RMB 1.405 billion in 2023 to RMB 2.485 billion by 2027, reflecting a CAGR of approximately 20.1% [3][5]. - Net profit attributable to shareholders is expected to fluctuate, with a decline to RMB 192 million in 2024, followed by a recovery to RMB 403 million by 2027 [3][5]. - The company’s operating cash flow improved significantly, reaching RMB 519 million in 2024, a 64.87% increase [11]. Business Segments - AI products and services revenue is forecasted to surge from RMB 273 million in 2024 to RMB 1.032 billion by 2027, with an impressive growth rate of 1255.99% in 2024 [8][12]. - The cloud products and services segment is expected to grow steadily, with revenue increasing from RMB 458.24 million in 2024 to RMB 626.66 million by 2027 [8]. - The industrial engineering and electrical products segment is projected to grow from RMB 456.50 million in 2024 to RMB 658.53 million by 2027 [8]. Competitive Positioning - The company is focusing on optimizing its self-developed "Le Series" industrial software, enhancing its core competitiveness with 12 industry packages and 156 industrial components [13]. - The launch of the "Ling Series" AI agent aims to address various industry needs, showcasing the company's commitment to leading the digital and intelligent ecosystem in the industrial sector [12][13].

Investment Rating - The report maintains an "Outperform" rating for the company [2][14]. Core Insights - The company is experiencing high revenue growth and significant cash flow optimization, driven by its AI+SaaS ecosystem, which is facilitating breakthroughs in both small and medium-sized enterprises (SMB) and key accounts (KA) markets [2][16]. - The commercialization of AI agents is accelerating, contributing to sustained performance growth for the company [2][16]. Financial Summary - The company’s revenue is projected to grow from 1.56 billion RMB in 2024 to 4.33 billion RMB by 2027, reflecting a compound annual growth rate (CAGR) of 51.9% from 2025 to 2027 [4][7]. - The net profit attributable to shareholders is expected to improve significantly, moving from a loss of 0.04 million RMB in 2025 to a profit of 3.50 million RMB by 2027, indicating a growth rate of 3615.8% in 2026 [4][7]. - The operating cash flow is expected to turn positive, with a net inflow of 138 million RMB in 2024, compared to a negative cash flow of 122 million RMB in the previous year [4][16]. Business Segments - The company’s SaaS business is anticipated to generate revenue of 1.14 billion RMB in 2025, with a growth rate of 35.0% and a gross profit margin of 85.0% [8][10]. - The precision marketing service segment is projected to achieve revenue of 931 million RMB in 2025, with a growth rate of 30.0% and a gross profit margin of 13.5% [10][11]. - The newly introduced Agent integrated machine is expected to generate 300 million RMB in revenue in 2025, with a gross profit margin of 42.0% [10][11]. Valuation - The target price for the company is set at 82.80 HKD, based on a sum-of-the-parts (SOTP) valuation method, reflecting a total market value of approximately 212.19 billion HKD [14][16].